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NF-jB is a pleiotropic transcription factor involved in
multiple processes, including inflammation and oncogen-
esis. We have previously reported that COMMD1 represses
jB-dependent transcription by negatively regulating
NF-jB–chromatin interactions. Recently, ubiquitination of
NF-jB subunits has been similarly implicated in the
control of NF-jB recruitment to chromatin. We report
here that COMMD1 accelerates the ubiquitination and
degradation of NF-jB subunits through its interaction
with a multimeric ubiquitin ligase containing Elongins B
and C, Cul2 and SOCS1 (ECSSOCS1). COMMD1-deficient
cells demonstrate stabilization of RelA, greater nuclear
accumulation of RelA after TNF stimulation, de-repres-
sion of several jB-responsive genes, and enhanced
NF-jB-mediated cellular responses. COMMD1 binds to
Cul2 in a stimulus-dependent manner and serves to facili-
tate substrate binding to the ligase by stabilizing the
interaction between SOCS1 and RelA. Our data uncover
that ubiquitination and degradation of NF-jB subunits
by this COMMD1-containing ubiquitin ligase is a novel
and critical mechanism of regulation of NF-jB-mediated
transcription.
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Introduction
NF-kB is a dimeric transcription factor that controls expres-
sion of genes involved in multiple processes including im-
munity, apoptosis, and cell cycle progression (Karin and Lin,
2002). In mammals, NF-kB subunits are encoded by five
genes (RELA, RELB, REL, NFKB1, and NFKB2). All subunits
share an B300 amino-acid region of homology termed the
Rel homology domain (RHD) that mediates DNA binding and
dimerization. The NFKB1 and NFKB2 genes encode large
precursor polypeptides known as p105 and p100, which are
cleaved into the mature p50 and p52 subunits, respectively.
NF-kB is ordinarily sequestered in the cytoplasm in a
transcriptionally inactive form as a result of interactions
with IkB proteins or, in the case of RelB, through its dimer-
ization with p105 or p100, which contain IkB-like domains
in their carboxy-termini. In response to a variety of stimuli,
transient nuclear translocation of NF-kB dimers takes place,
a prerequisite for kB-mediated transcription to occur. The
translocation event is triggered by phosphorylation of IkB
proteins by the multimeric IkB kinase, which leads to their
ubiquitination by the SCFb-TrCP ubiquitin ligase (Henkel et al,
1993; Chen et al, 1995; Yaron et al, 1998). Ubiquitinated IkB
is then quickly degraded allowing nuclear translocation of
NF-kB to occur. Once in the nucleus, NF-kB complexes bind
to cognate DNA sequences present in an array of promoters
resulting in gene expression.
In addition to nuclear translocation, transcriptional activa-
tion by NF-kB requires recruitment of co-activators and the
displacement of co-repressor complexes. This is mediated
through an intricate set of nuclear events that involve post-
translational modifications of NF-kB subunits, including
phosphorylation and acetylation (Sakurai et al, 1999; Chen
et al, 2001; Zhong et al, 2002).
In order to achieve controlled expression of its gene
targets, the termination of NF-kB-mediated transcriptional
responses is tightly regulated. Nuclear export of NF-kB com-
plexes is a major step in the regulation of this pathway.
Through a negative feedback loop, NF-kB induces the re-
synthesis of IkB proteins, ultimately driving nuclear export
of NF-kB and termination of transcription (Hoffmann et al,
2002). Despite the important role that IkB proteins play in
regulating the nuclear pool of NF-kB, other factors are likely
involved. For example, NF-kB remains largely excluded from
the nucleus in cells that are profoundly deficient in IkB
proteins, in contrast to the mostly nuclear localization that
results from stimulus-dependent degradation of IkB
(Tergaonkar et al, 2005), suggesting that other pathways are
also involved in the control of nuclear NF-kB levels.
We have previously reported that a factor named MURR1,
now referred to as COMMD1, is a ubiquitously expressed
inhibitor of NF-kB (Ganesh et al, 2003; Burstein et al, 2005).
COMMD1 interferes with HIV-1 replication, a process that is
dependent on kB-mediated transcription (Ganesh et al, 2003).
More recently, we identified that COMMD1 is the prototype of
a family of 10 factors known as COMMD proteins that also
function to repress NF-kB (Burstein et al, 2005). The defining
characteristic of all family members is the presence of an
B70 amino-acid region of high homology in their extreme
carboxy-termini termed the COMM domain, which serves as
an interface for COMMD–COMMD protein interactions
(Burstein et al, 2005). COMMD proteins interact with NF-kB
subunits but, unlike IkB-a, do not control the translocation of
NF-kB from the cytosol to the nucleus (Burstein et al, 2005).
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Rather, COMMD1 is recruited to kB-responsive promoters
and decreases the duration of RelA–chromatin interactions
(Burstein et al, 2005). However, the precise mechanism for
this effect remained elusive.
Recent work has demonstrated that ubiquitination and
proteasomal degradation of nuclear RelA also participate in
the termination of NF-kB–chromatin interactions (Saccani
et al, 2004), prompting us to investigate a potential role for
COMMD1 in RelA ubiquitination. Indeed we demonstrate here
that COMMD1 promotes the ubiquitination and degradation
of NF-kB subunits. COMMD1 deficiency results in stabiliza-
tion of NF-kB and increased nuclear accumulation of RelA
following TNF stimulation. Furthermore, NF-kB activation in
COMMD1-deficient cells results in de-repressed kB-dependent
transcription and enhanced release of chemokines. We show
that endogenous COMMD1 immune complexes contain E3
ubiquitin ligase activity, as well as components of a Cullin-
containing ubiquitin ligase comprised of Elongins B and C,
Cul2 and SOCS1 (also known as ECSSOCS1), which has been
previously implicated in RelA ubiquitination. Immuno-
precipitation of COMMD1 from cells expressing Cul2 or the
ECSSOCS1 complex recovered ubiquitin ligase against RelA
in vitro. Finally, our data indicate that the interaction
of COMMD1 with ECSSOCS1 serves to stabilize SOCS1–RelA
interactions, thereby promoting binding of the substrate to
the enzyme. Overall, these studies define a novel pathway
by which kB-mediated transcription is regulated through
COMMD1-mediated ubiquitination of NF-kB subunits.
Results
COMMD1 promotes the ubiquitination of NF-jB
subunits
We have previously reported that COMMD1 inhibits kB-
mediated transcription by decreasing the duration of RelA–
chromatin interactions (Burstein et al, 2005). Recently,
ubiquitination and proteasomal degradation of DNA-bound
RelA was implicated in the control of RelA–chromatin inter-
actions (Saccani et al, 2004). Therefore, we explored the
possibility that ubiquitination of RelA might be a mechanism
for the inhibitory effects of COMMD1 on kB-mediated
transcription.
To investigate this, we examined the effect of COMMD1
expression on the levels of ubiquitinated NF-kB. First, ubi-
quitination of ectopically expressed, GST-tagged RelA was
evaluated by precipitating RelA and immunoblotting the
recovered material for polyubiquitin (Figure 1A). Heavily
ubiquitinated RelA was recovered after proteasomal blockade
only in cells coexpressing COMMD1. Utilizing a similar
approach, we next examined the effect of COMMD1 expres-
sion on the ubiquitination of endogenous RelA (Figure 1B). In
this case, endogenous RelA was immunoprecipitated and the
recovered material immunoblotted for polyubiquitin. Again,
expression of COMMD1 resulted in increased recovery of
ubiquitinated RelA. To corroborate that the ubiquitinated
material recovered in Figure 1A and B was RelA itself, a
complementary approach was utilized. Here ubiquitinated
proteins were recovered by precipitating ubiquitin (ectopi-
cally expressed as a fusion protein containing the His6 affinity
tag, His6-Ubi) and detecting the presence of RelA in this
fraction by immunoblotting. As shown in Figure 1C, precipi-
tation of cell lysates with Niþ -NTA agarose beads resulted in
the recovery of polyubiquitinated proteins only when the
cells were transfected to express His6-Ubi (and not from
vector-transfected cells). Slight and nonspecific binding of
RelA to the beads was detected, but modified RelA consisting
of material of increasing molecular weight was only recov-
ered from cells expressing His6-Ubi, indicating that this
material is ubiquitinated RelA (Figure 1C, upper panel). As
in Figure 1A and B, increased expression of COMMD1 accele-
rated RelA ubiquitination (Figure 1C, left panel), whereas
decreased expression of endogenous COMMD1 after RNA
interference (RNAi) diminished the amount of ubiquitinated
RelA (Figure 1C, right panel). Importantly, these changes
in the recovery of ubiquitinated RelA were not the result
of uneven expression of RelA or uneven precipitation of
polyubiquitinated proteins across the samples.
COMMD1 is a member of a larger protein family, which
also shares the ability to bind to and inhibit NF-kB activity;
therefore, we investigated the possibility of a similar effect
by other COMMD family members. Decreased expression of
COMMD6, 9, and 10 also resulted in decreased recovery of
ubiquitinated RelA (Supplementary Figure S1). Finally, using
a similar approach, we observed that COMMD1 expression
accelerated the ubiquitination of two other NF-kB subunits,
RelB and p52 (Figure 1D). Altogether, these results indicate
that COMMD1 promotes the ubiquitination of NF-kB.
COMMD1 affects the stability of RelA
If COMMD1-mediated ubiquitination of NF-kB subunits re-
sults in their degradation, we reasoned that COMMD1 should
alter the half-life and possibly the steady-state levels of NF-kB
subunits in cells. We examined this possibility in U2OS cells
with stable RNAi of COMMD1, resulting in nearly undetect-
able COMMD1 protein expression (Figure 2A) and 94%
suppression of the COMMD1 transcript (Figure 2B). In these
cells, basal levels of RelA protein were increased (Figure 2A)
and were not accompanied by changes in RELA mRNA
expression, suggesting a post-transcriptional effect of
COMMD1 on RelA (Figure 2B). In addition, similar increases
in the steady-state protein levels of RelB, p105, and p100
were observed (Figure 2A) in the absence of transcriptional
upregulation of their respective genes (data not shown).
This suggested an effect of COMMD1 on the protein
stability of RelA, and therefore the half-life of the protein
was examined. After metabolic labeling with 35S-labeled
methionine and cysteine, cell lysates were prepared at differ-
ent time points and endogenous RelA was immuno-
precipitated, resolved by SDS–PAGE, and then detected by
autoradiography. Consistent with the previous results, the
half-life of RelA was prolonged in COMMD1-deficient cells
(Figure 2C). Altogether, this indicated that COMMD1 desta-
bilizes RelA by promoting its ubiquitination and targeting
the protein for proteasomal degradation.
COMMD1 controls endogenous jB-mediated
transcription and cellular responses
The predicted functional effect of the stabilization of RelA
that we observed in COMMD1-deficient cells would be an
increase in kB-dependent transcription. Therefore, we exam-
ined the inducible mRNA expression of NF-kB-responsive
genes following TNF stimulation. Treatment with TNF
resulted in time-dependent increases in mRNA expression of
known NF-kB target genes such as ICAM1, BIRC3 (encoding
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c-IAP2), CXCL1, and CCL2 (Figure 2D). In each case,
COMMD1-deficient cells demonstrated increased transcrip-
tion of these genes, consistent with the notion that endogen-
ous levels of COMMD1 serve to restrict kB-mediated
transcription. Interestingly, the transcriptional effects
observed varied in each case (Figure 2D), and for other
NF-kB-regulated genes such as IL8 or TNF, the effects were
minimal (Supplementary Figure S2). These data indicate that
endogenous levels of COMMD1 serve to repress transcription
of a specific subset of NF-kB-inducible genes.
NF-kB-mediated transcription plays a critical role in a
number of cellular events, particularly the expression of
mediators of the inflammatory response in vivo, including
the production of several chemokines. Given the increased
rates of NF-kB-mediated transcription observed in COMMD1-
deficient cells (Figure 2D), we anticipated that these
cells might produce larger amounts of chemokines. To test
this possibility, we examined the ability of conditioned
media to induce chemotaxis of freshly isolated peripheral
mononuclear cells across a membrane barrier. As shown
in Figure 2E, conditioned media from COMMD1-deficient
cells induced a higher rate of chemotaxis than the control
cell line, particularly after TNF stimulation. As predicted,
this increased chemotaxis rate correlated with increased
secretion of NF-kB-inducible chemokines into the media
such as CCL2 (Figure 2F), a chemokine whose mRNA
expression was also upregulated in these cells (Figure 2D,
fourth panel).
COMMD1 deficiency alters the kinetics of nuclear
accumulation of RelA
The data thus far indicated that COMMD1 promotes the
ubiquitination of RelA and affects kB-mediated transcription
and cellular responses, such as the production of chemo-
kines. Given our prior observations that COMMD1 negatively
regulates RelA–chromatin interactions (Burstein et al, 2005),
we reasoned that one potential outcome of COMMD1 defi-
ciency would be decreased RelA ubiquitination leading
to enhanced accumulation of nuclear RelA. To study this
latter possibility, nuclear extracts of control and COMMD1-
deficient cells were prepared at various time points following
pulsed TNF stimulation. As shown in Figure 3A, COMMD1
Figure 1 COMMD1 promotes the ubiquitination of NF-kB subunits. (A) Ubiquitination of RelA. HEK 293 cells were transfected with COMMD1
or a vector control, along with GST-RelA. Cells were treated with Lactacystin (10mM) for 3 h before lysis with Triton X-100 buffer. RelA was
precipitated (PD) using glutathione (GSH) beads and the recovered material was immunoblotted for ubiquitin (Ubi). (B) Ubiquitination of
endogenous RelA. Cells were transfected with COMMD1 (or vector control) as in (A), and endogenous RelA was immunoprecipitated from cell
lysates prepared with Triton X-100 buffer. The recovered material was immunoblotted for ubiquitin. (C) Effects of overexpression and
underexpression of COMMD1 on RelA ubiquitination. HEK 293 cells were transfected with His6-ubiquitin (His6-Ubi) or a vector control, along
with HA-RelA. These cells were co-transfected with a vector control or COMMD1 (left panel), or with control or COMMD1-specific siRNA (right
panel). Ubiquitinated material was precipitated from cell lysates prepared with Triton X-100 buffer, using Ni-NTA agarose beads. The recovered
material was immunoblotted for RelA (HA) and ubiquitin. (D) Effects on other NF-kB subunits. HEK 293 cells were transfected as in (C), except
that HA-RelB (left panel) or HA-p52 (right panel) was used.
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deficiency resulted in greater nuclear accumulation of RelA,
and the differences observed were not accounted for by the
levels of IkB-a as COMMD1-deficient cells had equal or
higher levels of IkB-a at every time point (Figure 3B).
Interestingly, despite the prolongation in the half-life of
RelA (Figure 2C), the increased accumulation of nuclear
RelA in these cells was not a sustained effect and was only
noticeable during the peak times of 20 and 45 min post-
stimulation. This observation correlated with a faster and
higher rate of IkB-a protein resynthesis in COMMD1-deficient
cells (Figure 3B), explained in part by modest increases in
mRNA expression (Supplementary Figure S3). This is con-
sistent with the known negative feedback loop by which
NF-kB activates transcription of NFKBIA (the gene encoding
IkB-a), an event known to promote nuclear export of NF-kB
(Hoffmann et al, 2002).
Figure 2 COMMD1 deficiency stabilizes RelA and de-represses endogenous kB-dependent transcription and cellular events. (A) COMMD1
deficiency results in higher basal levels of RelA. U2OS cells were stably infected with lentiviruses targeting a control gene (shControl) or
COMMD1 (shCOMMD1). Once stable polyclonal cell lines were established, cell lysates were prepared with Triton X-100 buffer for
immunoblotting as indicated. (B) COMMD1 deficiency does not affect mRNA levels of RELA. In the same cells, mRNA was extracted and
the levels of COMMD1 and RELA expression were determined by qRT–PCR and expressed as % compared to the control line. (C) The half-life of
RelA is prolonged in COMMD1-deficient cells. Cells were metabolically labeled with 35S-labeled methionine and cysteine and cell lysates were
prepared at increasing time intervals as indicated. After immunoprecipitation of RelA, the recovered material was resolved by SDS–PAGE and
subjected to autoradiography. (D) COMMD1 deficiency results in enhanced transcription of several kB-responsive genes. COMMD1-deficient
and control cell lines were stimulated with a 10 min pulse of TNF, rinsed in PBS, and placed in normal media. Extraction of mRNA was
performed for qRT–PCR of the indicated gene transcripts. (E) COMMD1-deficient cells produce greater amounts of chemotactic factors.
Conditioned media from untreated or TNF-treated cells (12 h) were utilized. The ability of the media to induce chemotaxis was determined by
monitoring the migration of fluorescently labeled peripheral mononuclear cells across a membrane barrier (and expressed as a rate of
fluorescence change over time). (F) COMMD1-deficient cells secrete greater amounts of CCL2. Levels of CCL2 in the conditioned media
(prepared similarly as in (E)) were determined by ELISA.
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In order to examine the effect of COMMD1 on nuclear RelA
levels in the absence of IkB-mediated nuclear export, we
examined the kinetics of TNF-induced nuclear accumulation
of RelA after blocking new protein synthesis with cyclohex-
imide (CHX). The presence of this inhibitor largely abrogated
IkB-a resynthesis (Figure 3C compared to B). Under these
conditions, nuclear accumulation of RelA following TNF
treatment was more sustained and, importantly, remained
significantly elevated in COMMD1-deficient cells compared to
the control cells (Figure 3C). Altogether, these data indicate
that COMMD1-mediated ubiquitination of RelA affects
its stability in the nuclear compartment, consistent with
the observation that COMMD1 decreases RelA–chromatin
interactions.
COMMD1 associates with an endogenous ubiquitin
ligase
Although COMMD1 can accelerate the ubiquitination of RelA,
it remained to be determined whether this was a direct effect
on ubiquitination, or an indirect effect that subsequently
facilitates the ubiquitination of RelA. Given that COMMD
proteins do not possess any known catalytic activity, we
examined first whether COMMD1 could interact with an
endogenous ubiquitin ligase. To that end, COMMD1 immuno-
precipitates were offered as a potential source for E3 ubiqui-
tin ligase activity to an in vitro ubiquitination reaction
containing recombinant ubiquitin and the E1 and E2
enzymes. At the end of the reaction, the presence of E3
ubiquitin ligase activity was determined by the formation of
Figure 3 COMMD1 deficiency alters the nuclear accumulation of RelA. (A) COMMD1 deficiency results in greater accumulation of nuclear
RelA after TNF treatment. U2OS COMMD1-deficient and control cell lines were stimulated with a 10 min pulse of TNF. At the indicated time
point, cells were harvested and nuclear extracts were prepared for Western blot analysis of RelA in the nuclear fraction (and GCN5 as a loading
control). Densitometry analysis is also presented. (B) Greater nuclear accumulation of RelA is not due to alterations in IkB-a degradation or
resynthesis. U2OS cells were treated in an identical manner as in the experiment performed in (A) and IkB-a degradation was evaluated by
immunoblotting and densitometry. (C) COMMD1 deficiency promotes greater nuclear accumulation of RelA independent of IkB-a levels.
Similar to (A), U2OS cells were stimulated with a 10 min pulse of TNF, and medium containing CHX (30 mM) was then added. Nuclear extracts
were prepared at the indicated time intervals and immunoblotted for RelA. In addition, IkB-a levels were evaluated utilizing the cytosolic
fractions (bottom panel). Representative data and densitometry analysis are presented.
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polyubiquitin chains. As can be appreciated in Figure 4A,
COMMD1 immunoprecipitates catalyzed the formation of
polyubiquitinated material in the presence of ATP. This effect
was far stronger than the contaminating activity that co-
precipitated with the preimmune serum and indicated that
endogenous COMMD1 interacts with a protein complex
possessing E3 ubiquitin ligase activity.
COMMD1 interacts with the ECSSOCS1 complex,
a Cullin-containing ubiquitin ligase
Previous work identified that SOCS1 can induce the ubiqui-
tination and degradation of RelA (Ryo et al, 2003). SOCS1 is
a member of a large family of proteins containing the con-
served carboxy-terminal SOCS box domain. These factors can
form, through their SOCS box, part of multimeric ubiquitin
ligases that contain a Cullin protein. These complexes are
referred to as ECS and contain Elongins B and C, Cullin 2 or 5,
and a SOCS box containing protein (Figure 4B) and are
similar in structure to the better known Cul1-containing
SCF complexes (Willems et al, 2004). An ECS complex
containing SOCS1 (designated as ECSSOCS1) is involved in
the ubiquitination of various targets, including JAK2, IRS1,
and IRS2 (Rui et al, 2002; Ungureanu et al, 2002).
We have previously reported that COMMD1 interacts
with Cul1, a member of the Cullin family that is highly
homologous to Cul2 (Ganesh et al, 2003). Given the finding
that COMMD1 immune complexes contain E3 ubiquitin
ligase activity and that ECSSOCS1 has been implicated in the
Figure 4 COMMD1 interacts with the Cullin-containing ECSSOCS1 complex. (A) COMMD1 immunoprecipitates possess endogenous E3
ubiquitin ligase activity. An in vitro ubiquitination reaction containing recombinant E1, E2, and ubiquitin was supplemented with
immunoprecipitates prepared with COMMD1 antibody or preimmune serum control. The presence of E3 activity was determined by the
formation of polyubiquitin chains, as detected by immunoblotting. (B) Schematic representation of the ECSSOCS1 complex. SOCS1 is the
substrate binding subunit of the complex. An Elongin B and C complex serves as an adaptor linking SOCS1 to Cul2, which in turn interacts with
the RING finger protein Rbx1. (C) Interaction between endogenous COMMD1 and SOCS1. NIH-SR cells were lysed with Triton X-100 buffer and
COMMD1 antibodies or a control preimmune serum was used for immunoprecipitation. The recovered material was immunoblotted for SOCS1.
(D) COMMD1 interacts with several components of ECSSOCS1. HEK 293 cells were transfected with plasmids expressing Elongin C, Cul2, SOCS1,
or COMMD1 in fusion with GST, along with COMMD1-Flag in each case. TNF stimulation consisted of 30 min. After lysis with RIPA buffer, ECS
components (or COMMD1-GST) were precipitated with GSH beads and the recovered material was immunoblotted for COMMD1 (Flag).
(E) COMMD1–Cul2 interactions are inducible upon TNF stimulation. Similar to the experiment shown in (D), cells were transfected to express
GST-Cul2 and COMMD1-Flag. Cells were stimulated with TNF for 10 min and then placed in fresh media. The cells were lysed in RIPA buffer at
the indicated time points and Cul2 was precipitated using GSH beads. The recovered material was immunoblotted for COMMD1 (Flag).
(F) Endogenous COMMD1 and Cul2 interactions. After TNF stimulation, either as a 10 min pulse or a sustained exposure, endogenous
COMMD1 was immunoprecipitated at the indicated time points or the recovered material was immunoblotted for endogenous Cul2.
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ubiquitination of RelA, we investigated the possibility that
COMMD1 could interact with this complex. Immuno-
precipitation of endogenous COMMD1 resulted in the
co-precipitation of endogenous SOCS1, consistent with an
interaction between these two proteins (Figure 4C). Next,
various components of the ECSSOCS1 complex were expressed
in Human embryonic kidney (HEK) 293 cells, precipitated
from cell lysates, and the recovered material was immuno-
blotted for COMMD1. As shown in Figure 4D, Elongin C,
Cul2, and SOCS1 (but not the control GST protein)
co-precipitated with COMMD1. In addition, the interactions
of COMMD1 with Elongin C and Cul2 (but not SOCS1) were
enhanced by TNF stimulation. Interestingly, the ability of
COMMD1 to interact with itself, an event mediated by the
conserved COMM domain (Burstein et al, 2005), was also
enhanced by TNF stimulation (Figure 4D). In reciprocal
experiments, precipitation of COMMD1 resulted in the
recovery of components of the ECS complex (including
Elongin C, Cul2, SOCS1, and Rbx1) and these interactions
were mediated by the COMM domain of COMMD1
(Supplementary Figure S4).
Given the TNF-inducible nature of COMMD1–Cul2 bind-
ing, we investigated next the temporal profile of this inter-
action. Cells expressing Cul2 were stimulated with a pulse
of TNF and lysates were prepared at different time points
following stimulation. Cul2 was immunoprecipitated and the
recovered material was immunoblotted for COMMD1. As
before, TNF treatment induced greater recovery of
COMMD1 over time, with the peak of the effect taking
place 2 h after stimulation (Figure 4E). Similar experiments
were performed by immunoprecipitating endogenous
COMMD1 and detecting the co-precipitation of endogenous
Cul2 after TNF stimulation (Figure 4F). As before, TNF
augmented the interaction between COMMD1 and Cul2,
and this effect peaked at 2 h, irrespective of whether the
stimulation was provided as a pulse or sustained exposure to
TNF. Altogether, these data demonstrated a physical inter-
action between COMMD1 and the ECSSOCS1 complex, which
is inducible upon activation of the NF-kB pathway, and
suggested the possibility that this might be responsible for
COMMD1-directed RelA ubiquitination.
COMMD1-directed ubiquitination is mediated through
ECSSOCS1
Given the interaction of COMMD1 with the ECSSOCS1 com-
plex, previously implicated in RelA ubiquitination, we inves-
tigated if COMMD1 could be operating through this ligase.
To that end, we examined the ability of COMMD1 to induce
RelA ubiquitination after RNAi-mediated suppression of
either Cul2 or SOCS1. COMMD1 expression induced the
accumulation of ubiquitinated RelA in control cells, whereas
this event was prevented in cells deficient in either Cul2
or SOCS1 (Figure 5A). This experiment was consistent with
the notion that expression of the endogenous ECSSOCS1 com-
plex is required for the effects of COMMD1. Next, we
examined the effects of ECSSOCS1 expression on the rates of
RelA ubiquitination. Expression of Cul2 and SOCS1 increased
the recovery of ubiquitinated RelA and this effect was
enhanced by concurrent expression of COMMD1, particularly
in Cul2-expressing cells (Figure 5B), and to a lesser extent
after proteasomal blockade in SOCS1-expressing cells (data
not shown).
The effect that the expression levels of ECSSOCS1 had on the
recovery of ubiquitinated RelA from cells supported the
notion that COMMD1-directed ubiquitination is mediated
through the ECSSOCS1 complex. Therefore, we set out to test
this possibility in an in vitro ubiquitination system. COMMD1
immunoprecipitates were provided as an E3 ubiquitin ligase
to a reaction containing recombinant ubiquitin, the E1 and E2
enzymes, and purified GST-RelA as ubiquitination substrate
for the reaction. We prepared COMMD1 immunoprecipitates
from cells transfected with Cul1, Cul2, Cul5, or the corre-
sponding expression vector as a control. Despite the ability of
COMMD1 to interact with all three Cullins (data not shown),
only COMMD1 immune complexes recovered from cells
expressing Cul2 were capable of catalyzing detectable poly-
ubiquitination of GST-RelA in vitro (Figure 5C). In a similar
approach, COMMD1-containing complexes were recovered
from cells coexpressing several ECSSOCS1 subunits (Elongin
C, Cul2, SOCS1, and Rbx1) or transfected with the corre-
sponding expression vector as a control. Again, the immuno-
precipitation of COMMD1 from ECSSOCS1-expressing cells was
able to recover an activity that ubiquitinates RelA in vitro
(Figure 5D).
COMMD1 and ECSSOCS1 cooperate to inhibit RelA by
promoting its degradation
Our data thus far indicated that the interaction of COMMD1
with the ECSSOCS1 complex is required for COMMD1-
mediated ubiquitination of RelA in cells and in vitro.
Therefore, we reasoned that these factors should have a
synergistic negative impact on NF-kB-mediated transcription.
We examined this possibility by determining the effects
of COMMD1 and ECSSOCS1 components on RelA-mediated
ICAM1 expression (Figure 5E). Cells were transfected with
RelA and, as expected, this induced strong expression of the
endogenous ICAM1 gene (Figure 5E, lane 3). Under the
conditions of this experiment, expression of COMMD1,
Elongin C, or Cul2 by themselves did not have a substantial
inhibitory effect on RelA-mediated transcription of ICAM1
(Figure 5E, lanes 4, 5, and 7). However, when combined with
COMMD1, both Elongin C and Cul2 had significant inhibitory
activity (Figure 5E, lanes 6 and 8). Similarly, SOCS1-mediated
inhibition of ICAM1 expression was further enhanced by
COMMD1 (Figure 5E, lanes 9 and 10).
The inhibition of ICAM1 expression correlated directly
with the ability of COMMD1 and ECSSOCS1 components to
induce reductions in RelA protein levels (Figure 5E, second
and third panels). The decreases in protein levels observed
were not due to changes in mRNA levels of RelA, and did not
occur with a deletion mutant of SOCS1 that cannot interact
with the catalytic components of the ubiquitin ligase (data
not shown), consistent with a post-transcriptional effect that
requires the activity of the ubiquitin ligase. Altogether, the
synergistic effects of COMMD1 and ECSSOCS1 on transcription
and RelA degradation indicate that these factors cooperatively
repress NF-kB.
COMMD1 serves as an adaptor between SOCS1
and Cul2
Next, we sought to understand the role of COMMD1 in the
activity of the ECSSOCS1 ubiquitin ligase. We began by exam-
ining to which component(s) of the complex COMMD1 binds
to directly. To this end, we tested the ability of COMMD1 to
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bind to deletion mutants of Cul2 and SOCS1 that cannot
interact with the rest of the ECSSOCS1 complex (schematic
representation of domains involved is shown in Figure 6E).
As expected, an amino-terminal deletion of Cul2 (Cul2 DN)
could not bind to Elongin C; however, COMMD1 binding to
this mutant was unaffected (Figure 6A, lanes 2 and 3). This
suggested that the carboxy-terminal end of Cul2 is involved
in COMMD1 binding and indeed, a carboxy-terminal deletion
of Cul2 (Cul2 DC) abrogated binding to COMMD1 (Figure 6A,
lane 4). Similar studies performed with SOCS1 indicated that
a deletion of its carboxy-terminal SOCS box (SOCS1 DSB) did
not affect COMMD1 binding although as expected it pre-
vented binding to Elongin C (Figure 6A, lanes 5 and 6). In
fact, the SH2 domain of SOCS1 was necessary and sufficient
for COMMD1 binding (Figure 6A, lanes 7 and 8), even though
this region alone is incapable of binding to the ECS complex.
Altogether, these studies indicated that COMMD1 can bind
independently with two components of the ECSSOCS1, namely
Cul2 and SOCS1, resembling the binding characteristics of the
adaptor Elongin B/C complex (Figures 4B and 6E).
COMMD1 facilitates the binding of SOCS1 to RelA
SOCS1 is the component of the ECSSOCS1 complex that binds
to its substrates, including RelA (Ryo et al, 2003).
Interestingly, COMMD1 associates with both SOCS1 and
RelA, and accelerates the ubiquitination of RelA, prompting
Figure 5 The ECSSOCS1 complex is required for COMMD1-mediated ubiquitination of RelA. (A) COMMD1-mediated ubiquitination of RelA
depends on the endogenous ECSSOCS1 complex. HEK 293 cells were transfected with His6-Ubi and RelA as before (Figure 1C), as well as siRNA
against Cul2, SOCS1, or a control target. Two days later, mRNA expression levels of Cul2 and SOCS1 were determined by qRT–PCR. In addition,
cell lysates were prepared with an 8 M urea buffer and ubiquitinated proteins were precipitated with Ni-NTA beads. The recovered material was
immunoblotted for RelA (HA) and ubiquitin. (B) COMMD1 and ECS components have additive effects on RelA ubiquitination. As before, cells
were transfected with His6-Ubi and RelA, along with SOCS1, Cul2, and COMMD1, as indicated. Lysates prepared with an 8 M urea buffer were
utilized for ubiquitin precipitation; the recovered material was immunoblotted for RelA and ubiquitin. (C, D) In vitro ubiquitination of RelA by
COMMD1 immunoprecipitates. An in vitro ubiquitination reaction containing recombinant E1, E2, ubiquitin, and GST-RelA as substrates was
provided with immunoprecipitates prepared with COMMD1 antibody or preimmune serum as a source for E3 activity. In (C), the
immunoprecipitates were prepared from cells expressing Cul1, Cul2, Cul5, or a vector control. In (D), the immunoprecipitates were prepared
from cells expressing ECSSOCS1 subunits (Elongin C, Cul2, SOCS1, and Rbx1) or a vector control. (E) COMMD1 and ECSSOCS1 cooperatively
inhibit RelA-mediated ICAM1 expression and promote RelA degradation. HEK 293 cells were transfected with RelA, along with Elongin C
(EloC), Cul2, SOCS1, or COMMD1 as indicated. Two days later, ICAM1 mRNA abundance was determined by qRT–PCR and expressed as fold
over the vector control sample. In addition, RelA (HA) and b-actin protein levels were concurrently determined by Western blot.
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us to investigate if COMMD1 facilitates SOCS1–RelA binding.
To this end, we examined the ability of SOCS1 to co-pre-
cipitate with RelA under increasing expression of COMMD1.
As shown in Figure 6B, precipitation of RelA resulted in
co-precipitation of SOCS1, which was enhanced by increased
expression of COMMD1 in a dose-dependent manner.
The ability of COMMD1 to interact with both SOCS1
and RelA and the cooperative effect of COMMD1 on the
Figure 6 COMMD1 interacts with both Cul2 and SOCS1 and facilitates SOCS1–RelA binding. (A) COMMD1 interacts independently with both
SOCS1 and Cul2. Full-length and specific deletion mutants of Cul2 and SOCS1 were expressed in fusion with GST, along with COMMD1-Flag.
Cul2 and SOCS1 were precipitated from cell lysates (RIPA buffer) and the recovered material was immunoblotted as indicated. (B) COMMD1
facilitates SOCS1–RelA interactions. HEK 293 cells were transfected with GST-RelA, SOCS1, and increasing amounts of COMMD1 as indicated.
Two days after transfection, the cells were lysed in RIPA buffer. RelA was precipitated from the lysate and the recovered material was
immunoblotted for SOCS1 (Flag). (C) SOCS1 binds to the amino-terminus of the RHD of RelA. Cells were transfected as in (B), this time
utilizing GST-RelA full-length and deletion constructs encompassing the amino acids indicated in the figure. Two days after transfection, cell
lysates were prepared with RIPA buffer and RelA was precipitated. The recovered material was immunoblotted for SOCS1 (HA) or RelA (GST).
(D) RelA binds to the entire amino-terminus of SOCS1. HEK 293 cells were transfected to express GST-SOCS1 or the deletion mutants indicated,
as well as RelA 1–180. Two days after transfection, the cells were lysed in RIPA buffer. SOCS1 was precipitated from the lysate and the recovered
material was immunoblotted for RelA 1–180 (HA) or SOCS1 (GST). (E) Schematic representation of COMMD1 interactions with the ECSSOCS1
complex. COMMD1 interacts independently with both SOCS1, at the level of its SH2 domain, and Cul2, at the level of its conserved carboxy-
terminus. The interaction between COMMD1 and Cul2 is inducible upon TNF stimulation, and COMMD1 in turn facilitates the binding of RelA
to SOCS1.
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SOCS1–RelA interaction suggested the possibility of a stabi-
lizing protein–protein interaction. Interestingly, SOCS1
co-precipitated with the first 180 amino acids of RelA
(Figure 6C), the same amino-terminal motif of the RHD that
is also involved in COMMD1 binding (Burstein et al, 2005).
Similar to the ability of COMMD1 to enhance SOCS1 binding
to full-length RelA, expression of COMMD1 also augmented
the binding of SOCS1 to this region of RelA (Supplementary
Figure S5).
This raised the possibility that SOCS1 binding to RelA
might be indirect and mediated through COMMD1.
However, unlike SOCS1 binding to COMMD1 that only
required the SH2 domain (Figure 6A), the entire amino-
terminal end of SOCS1 was required for SOCS1–RelA inter-
actions (Figure 6D). These data indicate that COMMD1 does
not mediate but rather enhances binding of SOCS1 with
RelA, altogether suggesting that COMMD1 stabilizes the
SOCS1–RelA interaction by cooperatively binding to the
same amino-terminal motif in RelA (Figure 6E).
Discussion
In this study, we examined the potential mechanism respon-
sible for COMMD1-mediated repression of NF-kB and its
ability to accelerate the dissociation of RelA from chromatin
(Burstein et al, 2005). Interestingly, others had reported that
ubiquitination of RelA also accelerates its release from chro-
matin (Saccani et al, 2004), suggesting that ubiquitination
of RelA might be responsible for the effects of COMMD1.
Indeed, we present evidence that COMMD1 promotes the
ubiquitination of NF-kB subunits and our data also indicate
that this effect is mediated by the interaction of COMMD1
with ECSSOCS1, a Cullin-containing ubiquitin ligase complex
previously implicated in RelA ubiquitination (Ryo et al,
2003). These events are physiologically important because
COMMD1 deficiency results in de-repression of several
endogenous NF-kB-responsive genes and enhanced kB-
mediated cellular responses such as the production of
chemokines. Finally, our studies indicated that the role of
COMMD1 in this process is to induce greater binding of the
substrate, RelA, to the SOCS1 subunit, ultimately promoting
its ubiquitination.
SOCS1 has been previously implicated in the control of
RelA levels and the data presented here indicate that SOCS1
functions in concert with the ECS complex. More importantly,
we present data indicating that the ability of COMMD1 to
ubiquitinate RelA is mediated through ECSSOCS1. COMMD1
interacts with components of the ECS complex, as shown at
the level of endogenous SOCS1 and Cul2 (Figure 4C and F)
and overexpressed ECS components (Figures 4D, E, and 6A
and Supplementary Figure S4). Similarly, COMMD1-mediated
ubiquitination of RelA in cells is hampered by ECS deficiency
(Figure 5A) and accentuated by overexpression of ECS com-
ponents (Figure 5B). Finally, COMMD1 immune complexes
contain ubiquitin ligase activity and can mediate the ubiqui-
tination of RelA in vitro when recovered from cells expressing
Cul2 and not other Cullins, or from cells expressing ECS
components (Figure 5C and D).
SOCS1 expression is under the control of the JAK/STAT
pathway, which stimulates transcription of the SOCS1 gene
(Naka et al, 1997) and promotes the stability of the SOCS1
protein through Pim-mediated phosphorylation (Chen et al,
2002). These effects predict that STATactivation should result
in negative crosstalk with the NF-kB pathway. In this regard,
NF-kB activation results in the expression of various inducers
of the STAT pathway (such as IL-6) that can upregulate
SOCS1 expression (Zhang et al, 1994), possibly providing
an autocrine negative feedback loop. This mechanism could
be important during inflammatory responses in vivo, when
multiple cytokines are coordinately activated. In addition, our
studies demonstrate that the SOCS1–COMMD1 interaction is
mediated by the SH2 domain of SOCS1 (Figure 5A), a region
that preferentially interacts with tyrosine phosphorylated
targets (Ungureanu et al, 2002). This suggests the possibility
that activation of tyrosine kinase(s) that might target
COMMD1 could enhance this interaction and provide addi-
tional crosstalk regulation of the NF-kB pathway.
Our previously reported data suggest that COMMD1-
mediated inhibition of NF-kB occurs in the nucleus, a
compartment where the protein can be readily identified
(Burstein et al, 2005). Although it is largely accepted that
the cytoplasmic pool of SOCS1 is responsible for its ability to
regulate JAK2 kinase activity (Endo et al, 1997), the presence
of a nuclear pool of SOCS1 is also well documented (Vuong
et al, 2004). Indeed, our analysis indicates that the main
components of the ECSSOCS1 complex, including SOCS1,
Elongin C, Cul2, and Rbx1, can be found in nuclear extracts
(Supplementary Figure S6).
Another important observation in our studies is that there
is dissociation between the duration of transcriptional
responses and nuclear RelA accumulation. The mRNA levels
for all kB-responsive genes evaluated here continued to
accumulate at time points when nuclear levels of RelA were
back to baseline (after 45 min; see Figures 2D and 3A). This
suggests that after RelA has been effectively exported into the
cytosol, other mechanisms are likely involved in the late
termination of transcription. In fact, the inducible COMMD1–
Cul2 interaction peaks at 2 h (Figure 4E and F), a time point
when nuclear export of RelA has been completed, suggesting
that the physiologic role of NF-kB ubiquitination is in late
transcriptional termination.
We have previously reported that COMMD1 binds to Cul1
(Ganesh et al, 2003), and more detailed examination indi-
cates that COMMD1 can bind to additional Cullins (GN Maine
and E Burstein, unpublished observations). This suggests the
possibility that COMMD1 might be a component of various
ubiquitin ligases targeting proteins other than NF-kB subunits
and might ultimately explain functions of COMMD1, such as
its role in copper metabolism, that appear unrelated to its
effects on NF-kB (van de Sluis et al, 2002; Burstein et al,
2004).
Altogether, this study demonstrates that COMMD1, acting
via a Cullin-containing ubiquitin ligase, represses kB-
mediated transcription through ubiquitination of NF-kB
subunits. COMMD1-mediated regulation of NF-kB through
ECSSOCS1 is part of a larger paradigm of transcriptional
regulation. Indeed, various Cullin-containing complexes
have been shown to play critical roles in the regulation of
other transcription factors such as c-Myc (von der Lehr et al,
2003) and HIF1a (Pause et al, 1997). Our data uncover that in
addition to the well-known events that control IkB protein
stability, regulation of the stability of the NF-kB subunits by
this COMMD1-containing ubiquitin ligase is a critical event
in the termination of kB-mediated transcription.
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Materials and methods
Plasmids and small interfering RNA
Expression vectors for RelB and p52 were generated by PCR
amplification of the corresponding coding sequences from plasmid
templates kindly provided by Dr Ranjeny Thomas and Dr Colin
Duckett, respectively. Expression vectors for Elongin C, Cul2,
SOCS1, and Rbx1 were generated by PCR amplification using as
templates the following IMAGE cDNA clones: 3923736, 4104375,
5179306/5093311, and 3138751, respectively. Deletion constructs for
Cul2 and SOCS1 were similarly generated with the amino-acid
boundaries of the encoded mutant proteins being Cul2 DN¼ 109–745,
Cul2 DC¼ 1–415, SOCS1 DSB¼ 1–157, SOCS1 DSB-SH2¼1–78,
SOCS1 SH2¼ 78–174. Information about the sequences of small
interfering RNA (siRNA) oligonucleotides utilized (chlorampheni-
col acetyl transferase, COMMD1, SOCS1, and Cul2, obtained from
Invitrogen) are available upon request. For stable RNAi utilizing
lentiviral delivery we introduced a cassette containing the histone 1
promoter and a short hairpin RNA into the FG12 plasmid (kindly
provided by Dr David Baltimore). All other plasmids used have
been described previously (Burstein et al, 2004, 2005).
Cell culture, transfection, and lentiviral production
HEK 293 cells, HEK 293T cells, U2OS cells, and NIH-SR cells were
obtained from ATCC. HEK 293, HEK 293T, and U2OS cells were
cultured in DMEM supplemented with 10% FBS and L-glutamine
(2 mM). NIH-SR cells were cultured in RPMI supplemented with
10% FBS, L-glutamine (2 mM), sodium pyruvate (1 mM), and
glucose (4.5 g/l). A standard calcium phosphate transfection
protocol was used to transfect plasmids and siRNA into HEK 293
cells (Burstein et al, 2004). TNF treatments (1000 U/ml; Roche)
were for variable amounts of time, as indicated in each experiment.
Production of lentiviruses for stable delivery of short hairpin RNA
constructs was performed as previously described utilizing plas-
mids kindly provided by Dr David Baltimore (Lois et al, 2002).
Quantitative RT–PCR
RNA extraction and RT–PCR methods were performed as previously
described (Burstein et al, 2005). Oligonucleotides and probes for
RELA, ICAM1, BIRC3, CXCL1, CCL2, TNF, and IL8 transcripts were
obtained from Applied Biosystems.
Immunoblotting and immunoprecipitation
The compositions of Triton lysis buffer and RIPA buffer have been
previously described (Burstein et al, 2005). In some experiments, an
8 M urea buffer (8 M urea, 50 mM Tris, pH 8.0, 300 mM NaCl, 50 mM
NaPO4, 0.5% NP-40) was used. All buffers were supplemented with
1 mM sodium orthovanadate and protease inhibitors (Roche).
Preparation of cytosolic and nuclear extracts, immunoprecipita-
tions, GSH precipitations, Ni-NTA precipitations, and immunoblot-
ting were performed as described previously (Burstein et al, 2004,
2005). The following antibodies were used: COMMD1 (Burstein
et al, 2005; Abnova), Flag (Sigma), HA (Sigma), ubiquitin
(Stressgen), RelA (Santa Cruz Biotechnology), RelB (Santa Cruz
Biotechnology), p52 (Upstate Biotechnology), Cul2 (Zymed, Up-
state Biotechnology, and Abnova), Elongin C (BioLegend), SOCS1
(Zymed, Abcam, Santa Cruz Biotechnology), Rbx1 (LabVision),
IkB-a (Upstate Biotechnology), GST (Santa Cruz), b-actin (Sigma),
a-tubulin (Molecular Probes), and GCN5 (Santa Cruz).
Metabolic labeling
One day prior, 8105 cells were seeded in a 10cm dish. They were
placed in a cysteine- and methionine-deficient medium (with 10%
dialyzed FBS) for 30 min, and 500mCi of 35S-labeled methionine and
cysteine (GE Healthcare) was added per plate for 1 h. The media
were then replaced with regular growth media supplemented with
excess non-radiolabeled methionine (2 mM) and cysteine (2 mM).
Denatured lysates were prepared by applying 50 mM Tris, 1% SDS,
5 mM DTT, and boiling the samples for 10 min at 951C. The buffer
was then supplemented with Triton X-100 lysis buffer to decrease
the SDS concentration to 0.2%. Samples were pre-cleared with
protein G Sepharose beads for 1 h at 41C and the supernatant
obtained after centrifugation was subjected to RelA immunopreci-
pitation (Santa Cruz Biotechnology, sc-372). The recovered material
at the end of immunoprecipitation was resolved by SDS–PAGE and
RelA was detected by autoradiography.
In vitro chemotaxis assay and chemokine measurement
Conditioned media before and after 12-h TNF stimulation were
used. Peripheral mononuclear cells were freshly isolated after
dextran sedimentation and Ficoll gradient centrifugation, as
previously described (Diamond et al, 1991). The cells were then
fluorescently labeled with Calcein-AM (Sigma) and chemotactic
migration across a membrane and toward conditioned media was
determined utilizing a 96-well FluoroBlock plate pre-coated with
fibronectin, according to the manufacturer’s instructions (BD
Biosciences). The plate was placed at 371C on a fluorometer (ABI
Cytofluor 4000) and cell migration was monitored every 15 min for
a total of 2 h. CCL2 levels in conditioned media were determined by
ELISA according to the manufacturer’s instructions (R&D systems).
In vitro ubiquitination reaction
Each reaction mixture consisted of recombinant ubiquitin (2.5mg/
reaction), E1 (Uba1, 50 ng/reaction), E2 (UbcH5a, 100 ng/reaction),
and ATP regenerating buffer (Boston Biochem), resuspended in
reaction buffer (40 mM HEPES pH 7.9, 60 mM potassium acetate,
2 mM DTT, 5 mM MgCl2, 10% glycerol). The material obtained from
immunoprecipitation of COMMD1 (or control) was added as a
source for E3 ubiquitin ligase activity. Recombinant GST-RelA was
used as the substrate in these reactions and was prepared by
expression in 293 cells and affinity purification using standard
protocols.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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